Literature DB >> 19428264

Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.

V N Mitin1, V N Kulakov, V F Khokhlov, I N Sheino, A M Arnopolskaya, N G Kozlovskaya, K N Zaitsev, A A Portnov.   

Abstract

In this study efficacy of antineoplastic action of gadolinium NCT and boron NCT in cases of canine melanoma and osteosarcoma was compared. Canine spontaneous tumors, such as melanoma and osteosarcoma, have clinical common features with human malignancies, so these tumors in dogs can be considered as clinical model of human melanoma and osteosarcoma. The study has been carried out on 33 dogs with oral cavity melanoma and 9 dogs with osteosarcoma. Dogs with spontaneous melanoma of oral cavity and osteosarcoma of extremities were selected by the results of clinical examination. Irradiation was carried out at the NCT facility of the IRT MEPhI reactor. Neutron irradiation without boron or gadolinium was chosen as a control method to evaluate the efficacy of NCT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428264     DOI: 10.1016/j.apradiso.2009.03.067

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  9 in total

Review 1.  Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.

Authors:  Micah John Luderer; Pilar de la Puente; Abdel Kareem Azab
Journal:  Pharm Res       Date:  2015-06-02       Impact factor: 4.200

Review 2.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

Review 3.  pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.

Authors:  Oleg A Andreev; Donald M Engelman; Yana K Reshetnyak
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

4.  Using 157Gd doped carbon and 157GdF4 nanoparticles in proton-targeted therapy for effectiveness enhancement and thermal neutron reduction: a simulation study.

Authors:  Farshid Tabbakh; Narayan S Hosmane; Suffian M Tajudin; Amir-Hossein Ghorashi; Nader Morshedian
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

5.  Magnetic resonance imaging, gadolinium neutron capture therapy, and tumor cell detection using ultrasmall Gd2O3 nanoparticles coated with polyacrylic acid-rhodamine B as a multifunctional tumor theragnostic agent.

Authors:  Son Long Ho; Hyunsil Cha; In Taek Oh; Ki-Hye Jung; Mi Hyun Kim; Yong Jin Lee; Xu Miao; Tirusew Tegafaw; Mohammad Yaseen Ahmad; Kwon Seok Chae; Yongmin Chang; Gang Ho Lee
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

Review 6.  Gadolinium Neutron Capture Therapy (GdNCT) Agents from Molecular to Nano: Current Status and Perspectives.

Authors:  Son Long Ho; Huan Yue; Tirusew Tegafaw; Mohammad Yaseen Ahmad; Shuwen Liu; Sung-Wook Nam; Yongmin Chang; Gang Ho Lee
Journal:  ACS Omega       Date:  2022-01-12

7.  In vivo neutron capture therapy of cancer using ultrasmall gadolinium oxide nanoparticles with cancer-targeting ability.

Authors:  Son Long Ho; Garam Choi; Huan Yue; Hee-Kyung Kim; Ki-Hye Jung; Ji Ae Park; Mi Hyun Kim; Yong Jin Lee; Jung Young Kim; Xu Miao; Mohammad Yaseen Ahmad; Shanti Marasini; Adibehalsadat Ghazanfari; Shuwen Liu; Kwon-Seok Chae; Yongmin Chang; Gang Ho Lee
Journal:  RSC Adv       Date:  2020-01-03       Impact factor: 4.036

8.  In vivo evaluation of the effects of combined boron and gadolinium neutron capture therapy in mouse models.

Authors:  Woonghee Lee; Kyung Won Kim; Jeong Eun Lim; Swarbhanu Sarkar; Jung Young Kim; Yongmin Chang; Jeongsoo Yoo
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

9.  In Vivo Accelerator-Based Boron Neutron Capture Therapy for Spontaneous Tumors in Large Animals: Case Series.

Authors:  Vladimir Kanygin; Aleksandr Kichigin; Alexander Zaboronok; Anna Kasatova; Elena Petrova; Alphiya Tsygankova; Evgenii Zavjalov; Bryan J Mathis; Sergey Taskaev
Journal:  Biology (Basel)       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.